ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,512.84
0.32%
Gold vs US Dollar
2,360.48
0.00%
Brent Oil
82.585
0.00%
Bitcoin
61,018.16
0.36%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Passage Bio Inc (PASG)

  7. Passage Bio Inc (PASG) News

Passage Bio (PASG)

Passage Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PASG
DateTimeSourceHeadlineSymbolCompany
22/04/202412:00GlobeNewswire Inc.Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing SummitNASDAQ:PASGPassage Bio Inc
05/03/202412:00GlobeNewswire Inc.Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship ProgramNASDAQ:PASGPassage Bio Inc
04/03/202422:22Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PASGPassage Bio Inc
04/03/202421:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PASGPassage Bio Inc
04/03/202412:15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PASGPassage Bio Inc
04/03/202412:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
04/03/202412:00GlobeNewswire Inc.Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business HighlightsNASDAQ:PASGPassage Bio Inc
29/02/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
27/02/202412:00GlobeNewswire Inc.Passage Bio to Participate in Upcoming Investor ConferencesNASDAQ:PASGPassage Bio Inc
14/02/202414:21Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PASGPassage Bio Inc
14/02/202400:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
14/02/202400:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
05/01/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
03/01/202421:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
03/01/202421:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
03/01/202421:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PASGPassage Bio Inc
29/12/202321:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
20/12/202312:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
20/12/202312:00GlobeNewswire Inc.Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic PrioritiesNASDAQ:PASGPassage Bio Inc
17/11/202321:30GlobeNewswire Inc.Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:PASGPassage Bio Inc
13/11/202312:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PASGPassage Bio Inc
13/11/202312:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
13/11/202312:00GlobeNewswire Inc.Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business HighlightsNASDAQ:PASGPassage Bio Inc
30/10/202311:00GlobeNewswire Inc.Passage Bio to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology ConferenceNASDAQ:PASGPassage Bio Inc
20/10/202321:30GlobeNewswire Inc.Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PASGPassage Bio Inc
25/09/202312:00GlobeNewswire Inc.Passage Bio to Present at Chardan’s 7th Annual Genetic Medicines ConferenceNASDAQ:PASGPassage Bio Inc
01/09/202321:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
07/08/202312:18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PASGPassage Bio Inc
07/08/202312:15GlobeNewswire Inc.Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business HighlightsNASDAQ:PASGPassage Bio Inc
07/08/202312:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PASGPassage Bio Inc
 Showing the most relevant articles for your search:NASDAQ:PASG

Your Recent History

LSE
GOLD
LSE
ALL
Atlantic Lithium
LSE
PET
Petrel Resources
LSE
ENQ
Enquest
LSE
GKP
Gulf Keystone Petroleum
LSE
AHT
Ashtead
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved